FEBRUARY 20, 2012

AUA 2009 - Bladder Cancer: Superficial - Racial Differences in Treatment and Outcomes Among Patients with Early Stage Bladder Cancer - Session Highlights

E-mail Print

CHICAGO, IL, USA (UroToday.com) - PCA3 is a new diagnostic test that is increasingly used in clinical practice. Its feasibility and performance has not been evaluated in a true screening population.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |